Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials.

T. Korkmaz,Selcuk E. Seber,G. Basaran
DOI: https://doi.org/10.1016/j.critrevonc.2015.10.006
IF: 6.625
2016-02-01
Critical Reviews in Oncology/Hematology
Abstract:
What problem does this paper attempt to address?